Vertebral Marrow Attention Trial (VMAT)

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 29, 2022

Primary Completion Date

July 12, 2024

Study Completion Date

September 18, 2024

Conditions
Lung Cancer
Interventions
OTHER

Evidence-based radiation dose limitation to the vertebral bone marrow

The only intervention that will occur during the radiation treatment planning process will be the application of evidence-based radiation dose limitations to the vertebral bone marrow during treatment plan optimization in order to attempt to limit Grade 3 Lymphopenia (G3L) toxicity.

Trial Locations (2)

37232

Vanderbilt-Ingram Service for Timely Access, Nashville

78229

Mays Cancer Center, UT Health San Antonio, San Antonio

All Listed Sponsors
lead

The University of Texas Health Science Center at San Antonio

OTHER